Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04278053 · ClinicalTrials.gov registry record · NA
Evaluation of Sports Supplements on Blood Flow
A NA study, sponsored by University of Arkansas, Fayetteville.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT04278053 is a NA study that has completed, run by University of Arkansas, Fayetteville. The registered enrollment target is 24 participants.
The verdict
NCT04278053, a NA study, has completed, sponsored by University of Arkansas, Fayetteville.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
Many athletes seek to increase their plasma (blood) nitric oxide content prior to exercise in order to augment vasodilation. Increased vasodilation during exercise, especially high intensity resistance training, allows for more blood flow to muscle tissues, which may give the athlete benefits such as increased work capacity and acute muscle hyperemia, which is commonly referred to as muscle pump. Pre-workout supplements are typically taken 30 minutes to 1 hour prior to the onset of exercise, so the current investigation seeks to determine if citrulline malate or nitrosigine can effect vasodilation within 1 hour of supplementation, and if so, which supplement is more effective. Based on previous findings, we hypothesize that a certain exercise intensity needs to be present for citrulline malate and nitrosigine to have an effect, so a change may not be observable at rest.
Interventions
- DIETARY_SUPPLEMENT inositol-stabilized arginine silicate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2018-10-15 |
| Est. Completion | 2019-05-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04278053
The ClinicalTrials.gov registry entry for NCT04278053 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arkansas, Fayetteville, which has 25 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which inositol-stabilized arginine silicate is the first listed.
NCT04278053 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04278053 about?
NCT04278053 is a clinical study titled "Evaluation of Sports Supplements on Blood Flow". Many athletes seek to increase their plasma (blood) nitric oxide content prior to exercise in order to augment vasodilation. Increased vasodilation during exercise, especially high intensity resistance training, allows for more blood flow to muscle tissues, which may give the athlete benefits such a...
What is the current status of trial NCT04278053?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2018-10-15. Estimated completion is 2019-05-08.
What interventions are being tested in trial NCT04278053?
The interventions under investigation include: inositol-stabilized arginine silicate (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04278053?
This trial is sponsored by University of Arkansas, Fayetteville, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.